The weekly litigation news digest is live. Subscribe now

IP Verse

Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof

Patent No. EP3682905 (titled "Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof") was filed by Moderna on Oct 3, 2012. The application was issued on Dec 1, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (10)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MAIWALDSep 1, 2022MAIWALD
PFIZERSep 1, 2022EDER
SANOFISep 1, 2022CARPMAELS & RANSFORD
SEQIRUS UKSep 1, 2022CARPMAELS & RANSFORD
WITHERS & ROGERSSep 1, 2022TOMBLING
ETHERNA IMMUNOTHERAPIESAug 31, 2022ARNOLD & SIEDSMA
BIONTECHAug 29, 2022WILK
GLAXOSMITHKLINEAug 26, 2022WEST
PATENT BOUTIQUEJun 24, 2022PATENT BOUTIQUE
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBMay 18, 2022WICHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3682905

MODERNA
Application Number
EP19216461A
Filing Date
Oct 3, 2012
Status
Granted And Under Opposition
Oct 29, 2021
Publication Date
Dec 1, 2021
External Links
Slate, EP3682905B1, Google Patents